ibandronic acid has been researched along with Rheumatism in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hakala, M; Hannonen, P; Heikkinen, J; Hienonen-Kempas, T; Kröger, H; Lehtonen-Veromaa, M; Paimela, L; Tuomiranta, T; Valleala, H | 1 |
| Curtis, JR; Saag, KG | 1 |
1 trial(s) available for ibandronic acid and Rheumatism
| Article | Year |
|---|---|
Once-monthly oral ibandronate provides significant improvement in bone mineral density in postmenopausal women treated with glucocorticoids for inflammatory rheumatic diseases: a 12-month, randomized, double-blind, placebo-controlled trial.
Topics: Aged; Bone Density; Bone Density Conservation Agents; Diphosphonates; Double-Blind Method; Female; Glucocorticoids; Humans; Ibandronic Acid; Middle Aged; Osteoporosis; Postmenopause; Rheumatic Diseases; Treatment Outcome | 2012 |
1 other study(ies) available for ibandronic acid and Rheumatism
| Article | Year |
|---|---|
Prevention and treatment of glucocorticoid-induced osteoporosis.
Topics: Alendronate; Bone Density Conservation Agents; Calcium; Cost-Benefit Analysis; Diphosphonates; Etidronic Acid; Female; Glucocorticoids; Humans; Ibandronic Acid; Male; Osteoporosis; Parathyroid Hormone; Patient Compliance; Practice Guidelines as Topic; Quality of Health Care; Rheumatic Diseases; Time Factors; Vitamin D; Vitamin K | 2007 |